Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. The company was founded in 1999 and is headquartered in Lund, Sweden.
| 26.83 | |
| 26.83 | |
| - | |
| 26.83 | |
| 26.83 | |
| 5.88-26.83 | |
| 1 796 M | |
| 65.439 | |
| 65 721 K | |
| 735 M | |
| 0.0385 | |
| 1.009 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CERAMENT G is the first combination product which has successfully navigated the DeNovo process. To date, MCRA has supported 5 of the 9 orthopedic DeNovos granted by the U.S.FDA, including the first 3...
NEW YORK, March 1, 2021 /PRNewswire/ -- WeissLaw LLP (PRNewsfoto/WeissLaw LLP) If you own shares in any of the companies listed above and would like to discuss our investigations or have any question...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
